中国2型糖尿病患者胰岛素治疗简便有效之选:预混胰岛素
Simple and effective selection of insulin therapy for type 2 diabetes mellitus in China:premixed insulin
摘要
我国2型糖尿病患病率不断增高,且患者血糖控制情况较差。随着疾病进展,大多数患者最终都需要使用胰岛素治疗,而预混胰岛素同时兼顾空腹及餐后血糖,方便、有效,可以更广泛的应用于糖尿病管理,使广大患者受益。
出处
《药品评价》
CAS
2015年第19期18-21,共4页
Drug Evaluation
参考文献18
-
1World Health Organization(WHO). World Health Organization Facts and Figures about diabetes: Fact sheet, http://www.who.int/mediacentre/ factsheets/fs312/erE, 2015-01.
-
2Duckworth WC, Abraira C, Moritz TE, et al. The duration of diabetes affects the response to intensive glucose control in type 2 subjects: The VA Diabetes Trial[J]. J Diabetes Complications, 2011, 25(6): 355-361.
-
3Holman RR, Farmer A J, Davies M J, et al. The 4-T Study Group. Three- year efficacy of complex insulin regimens in type 2 diabetes[J]. N Engl J Med, 2009, 361(18): 1736-1747.
-
4Buse JB, Wolffenbuttel BH, Herman WH, et al. The DURAbility of Basal versus Lispro mix 75/25 insulin E~cacy(DURABLE) trial: Comparing the durability of lispro mix 75/25 and glargine[J]. Diabetes Care, 2011, 34(2): 249-255.
-
5International Diabetes Federation. Glucose Control Therapy: Recommendations. In: Global Guideline for Type 2 Diabetes, http:// www.idf.org/sites/default/files/IDF%20T2DM%20Guideline.pdf, 2012- 11-22.
-
6Handelsman Y, Mechanick JI, Blonde L, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for developing a diabetes mellitus comprehensive care plan[J]. Endocr Pract, 2011, 17 (Suppl 2): S1-53.
-
7Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycaemia in type 2 diabetes: A patient-centered approach. Position statement of the American Diabetes Association(ADA) and the European Association for the Study of Diabetes(EASD)[J]. Diabetologia, 2012, 55(6): 1577-1596.
-
8American Diabetes Association. Standards of medical care in diabetes: 2012[J]. Diabetes Care, 2012, 35(Suppl 1): Sll-63.
-
9Schernthaner G, Barnett AH, Betteridge DJ, et al. Is the ADA/EASD algorithm for the management of type 2 diabetes(January 2009) based on evidence or opinion.'? A critical analysis[J]. Diabetologia, 2010, 53(7): 1258-1269.
-
10Liebl A, Prager R, Binz K, et al. Comparison of insulin analogue regimens in people with type 2 diabetes mellitus in the PREFER study: A randomized controlled trial[J]. Diabetes Obes Metab, 2009, 1 t(1): 45- 52.
二级参考文献4
-
1Diadetes Control and Complication Trial Research Group (OUT). The effect of intensive treatment of diabetes on the development and progres- sion of long time complications in insulin dependent diabetes mellitus [J]. N Eng JM ed,1993,329(8) :9771.
-
2UK Prospective Diabetes Study (UKPDS) Group. Intensive blood glu- cose control withsulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes ( UK-PDS 33 ) [ J ]. Lancet, 1998,35 (2) :837 - 853.
-
3Ning F, Zhang L, Dekker JM, et al. Development of coronary heart dis- ease and ischemic stroke in relation to fasting and 2-hour plasma glucose levels in the normal range [ J ]. Cardiovasc Diabetol,2012,11 (1) :76.
-
4Weng J, Li Y, Xu W, et al. Effect of intensive insulin therapy on 13-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial [ J ]. Lancet, 2008,37 ( 1 ) : 1753 - 1760.
-
1张洁琼,栾健.2型糖尿病患者胰岛素安全性的中国证据[J].药品评价,2015,0(19):33-37.
-
2向光大.人胰岛素与胰岛素类似物疗效和安全性比较的中国证据[J].药品评价,2015,0(19):38-41. 被引量：1
-
3赵蕾,祝开思.2型糖尿病胰岛素治疗起始时机的中国证据[J].药品评价,2015,0(19):29-32. 被引量：2
-
4李静,童南伟.磺脲类药物用于2型糖尿病患者的中国证据[J].药品评价,2015,12(5):19-22. 被引量：3
-
5高蕾莉.GLP-1受体激动剂用于2型糖尿病患者的中国证据[J].药品评价,2015,0(5):42-46. 被引量：1
-
6易敏,陈宏.胰岛素治疗1型糖尿病的中国证据[J].药品评价,2015,0(19):42-46.
-
7张洁,王战建.噻唑烷二酮类药物用于2型糖尿病患者的中国证据[J].药品评价,2015,12(5):23-26. 被引量：7
-
8赵进喜,王世东,申子龙.中医药用于2型糖尿病的中国证据[J].药品评价,2015,12(11):25-29. 被引量：4
-
9蔡晓凌.二甲双胍用于2型糖尿病患者的中国证据[J].药品评价,2015,0(5):15-18. 被引量：3
-
10李丽,祝开思.2型糖尿病基础胰岛素治疗的最新中国证据[J].药品评价,2015,0(19):13-17. 被引量：1
